FDA refuses to approve AstraZeneca’s sBLA for Fasenra in CRSwNP
The US Food and Drug Administration (FDA) has refused to approve the supplemental biologics license application (sBLA) of AstraZeneca’s asthma drug Fasenra (benralizumab) for the ... Read More
Medtronic to acquire ENT medical technology company Intersect ENT
Irish medical device company Medtronic has agreed to acquire Intersect ENT, an ear, nose, and throat (ENT) medical technology company, in an all-cash deal worth ... Read More
Lyra Therapeutics raises $30m for chronic rhinosinusitis drug candidates
Lyra Therapeutics has raised $30 million in a Series C financing round to advance its lead product candidates for the treatment of chronic rhinosinusitis (CRS). ... Read More